Assessment the effect of implementation of discharge plan on anxiety in patients with diabetes mellitus

Not Applicable

Recruiting

• Conditions: Diabetes mellitus.; Diabetes mellitus due to underlying condition; Diabetes m

• Registration Number: IRCT20181112041627N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

age more than eighteen years
ability to reading and writing
ability to understand and speak in Farsi
ability to self care
ability to speech and hearing
absence of dementia and cognitive problem
absence of endocrine gland diseases
not taking medications that reduce or increase cortisol (such as corticosteroids, anticonvulsants)
not taking anti-anxiety and tranquilizers (such as propranolol, clonazepam, etc.)
There is no underlying diseases
desire to participate in the study

Exclusion Criteria

Not fasting
Brushing during recent 4-5 hours
Not having saliva (in some cases like Sjogren's syndrome)
Presence of gingivitis
Unwilling to continue research
Discharge of the patient after 10 o'clock (due to stable salivary cortisol levels between 7 and 10 o'clock)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety Score in Beck's questionnaire. Timepoint: Anxiety Measurement at the beginning of the study (before the intervention) and half an hour after the intervention. Method of measurement: Anxiety Beck's questionnaire.;Salivary cortisol levels based on micrograms per deciliter. Timepoint: Anxiety Measurement at the beginning of the study (before the intervention) and half an hour after the intervention. Method of measurement: Saliva sample.